Saturday, February 2, 2019

The U.S. Food and Drug Administration on Friday declined to approve Alkermes Plc's opioid-based depression treatment, citing the need for additional data to prove the effectiveness of the drug.


from Reuters: Health News https://reut.rs/2Bhi3eG

Related Posts:

  • LATEST HEALTH NEWS(Reuters Health) - Patients who are treated in an intensive care unit (ICU) and survive are at increased risk of depression, a new study suggests. And depression in ICU survivors was linked with a higher risk of death in the … Read More
  • LATEST HEALTH NEWSThe differences in healthy food intake were small but statistically meaningful from Health https://ift.tt/2QdQSKr … Read More
  • LATEST HEALTH NEWS(Reuters Health) - A survey of people with food allergies who dine out successfully has found they employ quite a few strategies. from Reuters: Health News https://ift.tt/2r19ZsH … Read More
  • LATEST HEALTH NEWSAccording to the National Health Profile report, more than 40 million cases of acute respiratory infection were reported in India in 2016 from Health https://ift.tt/2DIAcE7 … Read More
  • LATEST HEALTH NEWS(Reuters Health) - Teens whose families eat dinner together are more likely to make healthy food choices, even when kids and parents have issues with communicating and connecting emotionally, a new study finds. from Reut… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner